Michael R. Bristow
2017
In 2017, Michael R. Bristow earned a total compensation of $547.7K as President and Chief Executive Officer at ARCA biopharma, a 4% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $91,300 |
|---|---|
| Option Awards | $137,281 |
| Salary | $302,856 |
| Other | $16,256 |
| Total | $547,693 |
Bristow received $302.9K in salary, accounting for 55% of the total pay in 2017.
Bristow also received $91.3K in non-equity incentive plan, $137.3K in option awards and $16.3K in other compensation.
Rankings
In 2017, Michael R. Bristow's compensation ranked 11,516th out of 14,666 executives tracked by ExecPay. In other words, Bristow earned more than 21.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,516 out of 14,666 | 22nd |
Division Manufacturing | 4,511 out of 5,770 | 22nd |
Major group Chemicals And Allied Products | 1,645 out of 2,074 | 21st |
Industry group Drugs | 1,360 out of 1,730 | 21st |
Industry In Vitro and In Vivo Diagnostic Substances | 55 out of 72 | 24th |
Source: SEC filing on April 18, 2018.
Bristow's colleagues
We found two more compensation records of executives who worked with Michael R. Bristow at ARCA biopharma in 2017.
News
ARCA biopharma CEO Michael Bristow's 2021 pay falls 50% to $527K
November 3, 2022
ARCA biopharma CEO Michael Bristow's 2020 pay jumps 258% to $1.1M
April 21, 2021
ARCA biopharma COO Thomas Keuer's 2019 pay slips 7% to $304K
October 28, 2020
ARCA biopharma COO Thomas Keuer's 2018 pay falls 29% to $327K
October 25, 2019